STAT3 Is a Serine Kinase Target in T Lymphocytes
暂无分享,去创建一个
[1] R. Rees,et al. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. , 1996, Journal of immunology.
[2] M. Owen,et al. The MAP Kinase Pathway Controls Differentiation from Double-Negative to Double-Positive Thymocyte , 1996, Cell.
[3] J. Darnell,et al. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Perlmutter,et al. Positive and negative selection invoke distinct signaling pathways , 1996, The Journal of experimental medicine.
[5] J. Lammers,et al. STAT3β, a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of Transcription* , 1996, The Journal of Biological Chemistry.
[6] D. Cantrell,et al. Interleukin‐2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. , 1996, The EMBO journal.
[7] J. Ihle,et al. STATs and MAPKs: obligate or opportunistic partners in signaling. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[8] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.
[9] T. Pawson,et al. MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes. , 1995, Oncogene.
[10] L. Sanders,et al. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Bridges,et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Darnell,et al. Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.
[13] N. Stahl,et al. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Miyajima,et al. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. , 1995, The EMBO journal.
[15] W. Paul,et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis , 1995, Molecular and cellular biology.
[16] L. A. Burns,et al. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway , 1995, Molecular and cellular biology.
[17] R. Abraham,et al. Protein-tyrosine kinase-dependent activation of STAT transcription factors in interleukin-2- or interleukin-4-stimulated T lymphocytes , 1995, The Journal of Biological Chemistry.
[18] W. Leonard,et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. , 1995, Immunity.
[19] J. Blenis,et al. Requirement of serine phosphorylation for formation of STAT-promoter complexes. , 1995, Science.
[20] D. Cantrell,et al. The regulation and function of p21ras during T-cell activation and growth. , 1995, Immunology today.
[21] P. Heinrich,et al. Interleukin‐6‐induced serine phosphorylation of transcription factor APRF: evidence for a role in interleukin‐6 target gene induction , 1995, FEBS letters.
[22] A. Cherniack,et al. Disassembly of Son-of-sevenless Proteins from Grb2 during p21 Desensitization by Insulin (*) , 1995, The Journal of Biological Chemistry.
[23] J. Blenis,et al. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP , 1995, Molecular and cellular biology.
[24] I. Kerr,et al. Activation of JAK kinases and STAT proteins by interleukin‐2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. , 1994, The EMBO journal.
[25] K. Siddle,et al. Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation. , 1994, The Biochemical journal.
[26] G. Drago,et al. Discrimination between two sites of phosphorylation on adjacent amino acids by phosphorylation site-specific antibodies to phospholamban. , 1994, The Journal of biological chemistry.
[27] S. McKnight,et al. An interleukin-4-induced transcription factor: IL-4 Stat. , 1994, Science.
[28] E. Liu,et al. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells , 1994, Nature.
[29] J. Johnston,et al. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2 , 1994, Nature.
[30] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[31] M E Greenberg,et al. Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. , 1993, Science.
[32] M. Kennedy,et al. Autophosphorylation of type II CaM kinase in hippocampal neurons: localization of phospho- and dephosphokinase with complementary phosphorylation site-specific antibodies. , 1993, Molecular biology of the cell.
[33] C. Crews,et al. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Crabtree,et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.
[35] Takashi Uchiyama,et al. Signal transduction by interleukin 2 in human T cells: Activation of tyrosine and ribosomal S6 kinases and cell‐cycle regulatory genes , 1992, Journal of cellular physiology.
[36] B. Groner,et al. Developmental and environmental regulation of a mammary gland-specific nuclear factor essential for transcription of the gene encoding beta-casein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] I. Mérida,et al. IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase. , 1991, Journal of immunology.
[38] R. Abraham,et al. Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes , 1991, Molecular and cellular biology.
[39] L. Cantley,et al. Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. , 1991, The Journal of biological chemistry.
[40] R. Perlmutter,et al. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.
[41] K. Dobashi,et al. Interleukin 2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in a T-cell line. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Greengard,et al. Production of phosphorylation state-specific antibodies. , 1991, Methods in enzymology.
[43] Kendall A. Smith,et al. Interleukin-2: inception, impact, and implications. , 1988, Science.
[44] H. Ohno,et al. Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. , 1987, Blood.